LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

Kodu・Aktsiate loetelu・Evolent Health Inc

Evolent Health Inc

Suletud

SektorTervishoid

9.62 0.1

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

9.35

Max

9.75

Põhinäitajad
By Trading Economics
Sissetulek	14M -51M
Müük	-39M 444M
Kasumimarginaal	-11.498
Töötajad	4,500
EBITDA	43M 14M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+64.66% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	6. nov 2025

Turustatistika
By TradingEconomics
Turukapital	-28M 1.1B
Eelmine avamishind	9.52
Eelmine sulgemishind	9.62

Uudiste sentiment

By Acuity

43%

57%

152 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

10.33 / 10.95 Toetus ja vastupanu

Evolent Health Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. sept 2025, 23:07 UTC

Omandamised, ülevõtmised, äriostud

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2. sept 2025, 22:10 UTC

Suurimad hinnamuutused turgudel

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2. sept 2025, 21:47 UTC

Tulu

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2. sept 2025, 16:52 UTC

Suurimad hinnamuutused turgudel

CleanCore Solutions Shares Drop After $175 Million Private Investment

2. sept 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2. sept 2025, 21:40 UTC

Omandamised, ülevõtmised, äriostud

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2. sept 2025, 21:07 UTC

Tulu

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2. sept 2025, 21:07 UTC

Tulu

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Rev $17.35B >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Adj EPS 78c >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q EPS 82c >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Net $782.5M >ATD.T

2. sept 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2. sept 2025, 20:53 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2. sept 2025, 20:51 UTC

Omandamised, ülevõtmised, äriostud

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. sept 2025, 20:27 UTC

Tulu

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2. sept 2025, 20:24 UTC

Omandamised, ülevõtmised, äriostud

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2. sept 2025, 20:18 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2. sept 2025, 20:17 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2. sept 2025, 20:16 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2. sept 2025, 20:16 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2. sept 2025, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2. sept 2025, 19:55 UTC

Tulu

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2. sept 2025, 19:50 UTC

Omandamised, ülevõtmised, äriostud

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2. sept 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2. sept 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2. sept 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2. sept 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2. sept 2025, 16:57 UTC

Omandamised, ülevõtmised, äriostud

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Evolent Health Inc Prognoos

Hinnasiht

By TipRanks

64.66% tõus

12 kuu keskmine prognoos

Keskmine 15.89 USD 64.66%

Kõrge 20 USD

Madal 13 USD

Põhineb 11 Wall Streeti analüütiku instrumendi Evolent Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

11 ratings

Osta

Hoia

Müü

Põhineb 11 analüütiku instrumendi Evolent Health Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

10.33 / 10.95Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Sentiment

By Acuity

152 / 371 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.